BioMarin Pharmaceutical Inc. - Company Profile and SWOT Analysis
SummaryBioMarin Pharmaceutical Inc. - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
BioMarin Pharmaceutical Inc. (BioMarin) is a biotechnology company dedicated to the research, development, and commercialization of medicines for rare genetic disorders. Its key products include therapies for mucopolysaccharidosis, achondroplasia, phenylketonuria, severe hemophilia A, and neuronal ceroid lipofuscinosis type 2, among others. BioMarin's medications are provided to patients through hospitals, non-US government agencies, authorized distributors, and select larger pharmaceutical wholesalers under the brand names Vimizim, Palynziq, Brineura, and Kuvan. It distributes products in the Americas, Asia, the Middle East, and Europe. Operates manufacturing facilities in the US and Ireland. BioMarin is headquartered in San Rafael, California, the US.
Scope
BioMarin Pharmaceutical Inc. - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
BioMarin Pharmaceutical Inc. (BioMarin) is a biotechnology company dedicated to the research, development, and commercialization of medicines for rare genetic disorders. Its key products include therapies for mucopolysaccharidosis, achondroplasia, phenylketonuria, severe hemophilia A, and neuronal ceroid lipofuscinosis type 2, among others. BioMarin's medications are provided to patients through hospitals, non-US government agencies, authorized distributors, and select larger pharmaceutical wholesalers under the brand names Vimizim, Palynziq, Brineura, and Kuvan. It distributes products in the Americas, Asia, the Middle East, and Europe. Operates manufacturing facilities in the US and Ireland. BioMarin is headquartered in San Rafael, California, the US.
Reasons To Buy
- Detailed information on BioMarin Pharmaceutical Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting BioMarin Pharmaceutical Inc. in the form of a SWOT analysis
- An in-depth view of the business model of BioMarin Pharmaceutical Inc. including a breakdown and examination of key business segments
- Intelligence on BioMarin Pharmaceutical Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about BioMarin Pharmaceutical Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
MarketLine, a world-leading provider of commercial intelligence, has over 400 experienced analysts, consultants, and researchers with regional and sector expertise in market sizing, competitor tracking, socio and macro economics, and business drivers.
For more than 15 years MarketLine has supported the research needs of investment banks, corporations, professional services firms, and academia with a unique mix of company, industry, country, city and financial data for every major industry and marketplace.
MarketLine’ holistic business intelligence report collection includes:
Industry Intelligence
‒ Industry Profiles
‒ Market Forecasts
‒ Porter’s Five Forces Analysis
Company Intelligence
‒ Company Profiles
‒ SWOT Analysis
‒ Financial Deals
Country and City Intelligence
‒ Country and City Profiles
‒ PEST/PESTLE Analysis
‒ Socio and macro-economic indicators
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.